Crossmark

An overview of positive cultures and clinical outcomes in septic patients: a sub-analysis of the Prehospital Antibiotics Against Sepsis (PHANTASi) trial

Crossref DOI link: https://doi.org/10.1186/s13054-019-2431-8

Published Online: 2019-05-21

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nannan Panday, Rishi S.

Lammers, Eline M. J.

Alam, Nadia

Nanayakkara, Prabath W. B. http://orcid.org/0000-0002-1555-3682
License Information

Text and Data Mining valid from 2019-05-21

Version of Record valid from 2019-05-21
More Information

Article History

Received: 5 February 2019

Accepted: 10 April 2019

First Online: 21 May 2019

Ethics approval and consent to participate

: The study protocol of the PHANTASi trial was approved by the medical ethical committee of the Amsterdam University Medical Center, Location VU University Medical Center, the coordinating center and all ethical bodies of each participating hospital. Due to the complexity of the PHANTASi trial, the ethics committees granted approval to obtain deferred consent when necessary. Informed consent before study enrolment or deferred consent was obtained from all patients or their legal representatives or surrogates. All effort was made by EMS personnel to obtain informed consent before study inclusion provided the acuity of the situation allowed it.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below